Application YC di Maven Bio
Maven Bio ha partecipato a Y Combinator nel batch Summer 2023 come azienda B2B. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.
- Batch YC
- Summer 2023
- Settore
- B2B
- Dimensione team
- 8
- Stato
- Active
- Lanciata
- 2023
Founder
Michael BradyFounder
Arjun MurthyFounder
Cosa fa Maven Bio
At Maven Bio, we’re transforming BioPharma knowledge work by pairing domain-specific AI with curated industry data - letting consultants, investors, and corporate teams move from question to decision with less manual work. Our integrated BioPharma-specific platform features four flagship modules: • Maven Workflows: Monitor Maven's domain-specific AI through structured research tasks - step by step - and finalize results with confidence. • Maven Atlas: Access hundreds of pre-built indication landscapes, or generate custom ones on demand for in-depth insights. • Maven Compass: Build precise lists of companies, drugs, trials, or documents with advanced filters - move faster with AI-driven filter suggestions. • Maven Assistant: Get instant answers to your BioPharma questions, complete with direct links to primary sources. Stop burning hours on manual data hunts. Maven Bio’s continuously updated database and collaborative AI features empower you to focus on strategic decisions. We offer usage-based pricing and usage-restricted trials, plus custom solutions for unique data sources or specialized workflows. Trusted by life science consultants, BD teams, and investors worldwide, Maven Bio delivers faster, deeper insights. Book a call to learn how our purpose-built AI can transform your research and accelerate your success.
Application YC di Maven Bio, ricostruita
Domanda per Y Combinator
Maven Bio, batch Summer 2023. Le vere domande del form, risposte da dati pubblici.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Maven Bio
The AI Platform for Life Sciences Intelligence
We build an AI platform focused on BioPharma research. Our product combines domain-specific AI with curated datasets to help consultants, investors, and corporate teams quickly find reliable insights on drugs, trials, companies, and indications. It includes four main modules: structured workflows to monitor AI-driven research, pre-built and custom indication maps, AI-assisted filtering for lists, and a bio-pharma question-answering assistant.
We live in Boston, MA and the company is based here and will remain so after YC.
Boston has strong biotech and pharma hubs and access to domain experts. Being here helps us stay close to early customers and industry partners.
21 risposte in più nell'application completa
Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.
Domande Frequenti
Questa è l'application YC reale di Maven Bio?
No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Maven Bio (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Maven Bio si presenterebbe a YC, non il testo che hanno inviato.
A quale batch YC apparteneva Maven Bio?
Maven Bio apparteneva al batch Summer 2023 di Y Combinator.
Chi ha fondato Maven Bio?
Maven Bio è stato fondato da Michael Brady, Arjun Murthy.
Cosa fa Maven Bio?
The AI Platform for Life Sciences Intelligence
Come leggo la ricostruzione completa della application?
Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Maven Bio, e di ogni altro batch YC, è in YC Insights.
Più startup YC come Maven Bio
